<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23076770</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>06</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-7276</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>30</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical &amp; experimental metastasis</Title>
                <ISOAbbreviation>Clin. Exp. Metastasis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.</ArticleTitle>
            <Pagination>
                <MedlinePgn>357-68</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10585-012-9542-9</ELocationID>
            <Abstract>
                <AbstractText>To analyze the prognostic value of the extent of peritumoral brain edema in patients operated for single brain metastases (BM), we retrospectively evaluated pre-operative magnetic resonance images in a discovery cohort of 129 patients and a validation cohort of 118 patients, who underwent neurosurgical resection of a single BM in two different hospitals. We recorded clinical parameters and immunohistochemically assessed the Ki67 index, the microvascularization patterns and the expression of hypoxia-induced factor 1 alpha (HIF1a) in the BM tissue specimens retrieved at neurosurgery. Statistical analysis including uni- and multivariate survival analyses were performed. Baseline characteristics were well balanced between the discovery and validation cohorts. In univariate analysis, we found a significant association of favorable overall survival time with young patient age, high Karnofsky performance score, low graded prognostic assessment (GPA) class, absence of extracranial metastases, adjuvant treatment with whole brain radiotherapy and, surprisingly, large brain edema. In multivariate analysis, only GPA and extent of brain edema remained independent prognostic parameters. The prognostic impact of the extent of brain edema was consistent in the two patient cohorts. Furthermore, we found a significant correlation of small brain edema with brain-invasive tumor growth pattern as assessed intraoperatively by the neurosurgeon, low neo-angiogenic activity and low expression of HIF1a. Extent of brain edema independently correlates with prognosis in patients operated for single BM. In conclusion, patients with small peritumoral edema have shorter survival times and their tumors are characterized by a more brain-invasive growth, lower HIF1a expression and less angiogenic activity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Spanberger</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Neuroradiology, Department of Radiology, Medical University of Vienna, Vienna, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berghoff</LastName>
                    <ForeName>Anna S</ForeName>
                    <Initials>AS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dinhof</LastName>
                    <ForeName>Carina</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ilhan-Mutlu</LastName>
                    <ForeName>Aysegül</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Magerle</LastName>
                    <ForeName>Manuel</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hutterer</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pichler</LastName>
                    <ForeName>Josef</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wöhrer</LastName>
                    <ForeName>Adelheid</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hackl</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Widhalm</LastName>
                    <ForeName>Georg</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hainfellner</LastName>
                    <ForeName>Johannes A</ForeName>
                    <Initials>JA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dieckmann</LastName>
                    <ForeName>Karin</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marosi</LastName>
                    <ForeName>Christine</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Birner</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prayer</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Preusser</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Clin Exp Metastasis</MedlineTA>
            <NlmUniqueID>8409970</NlmUniqueID>
            <ISSNLinking>0262-0898</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C497442">HIF1A protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001929" MajorTopicYN="N">Brain Edema</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
                <QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051795" MajorTopicYN="N">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName>
                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>6</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23076770</ArticleId>
            <ArticleId IdType="doi">10.1007/s10585-012-9542-9</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2005 May 4;97(9):643-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15870435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurooncol. 2010 Jan;96(1):103-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19957014</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5213-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18362333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurooncol. 1996 Jan;27(1):65-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8699228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2009 Dec 1;101(11):1919-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19826419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1985 Feb;35(2):219-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3969210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2004 Jul 15;22(14):2865-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15254054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2006 Jul 1;107(1):162-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16721804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuro Oncol. 2012 Jul;14(7):910-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22544733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):510-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17931798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2012 Aug;33(7):1349-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22322613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2003 Oct 15;21(20):3798-807</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12953099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2012 May;60(6):885-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22335622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009 Jun 10;4(6):e5857</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19516901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiat Oncol. 2011 Mar 02;6:23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21366924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurooncol. 2009 Dec;95(3):401-411</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19562257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1972 Jan;22(1):40-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5061838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2012 Feb 1;30(4):419-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22203767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2010 Jan;16(1):116-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20023634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2011 Jan 10;29(2):134-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21041710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2004 Sep 15;10 (18 Pt 1):6222-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15448011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2011 Jul;70(1):9-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21786296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2002 May 15;94(10):2698-705</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12173339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2011 May;11(5):352-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21472002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Neurol. 2009 Jul;16(7):874-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19473360</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2000 Sep 1;60(17):4959-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10987313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pathol. 2011 Sep;225(1):63-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21630273</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 May 19;473(7347):298-307</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21593862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Oncol. 2008 Nov;20(6):676-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18841050</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2466-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16286386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2008 Jul;53(1):39-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18613924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosurg. 2001 Aug;95(2):190-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11780887</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>